-
Mashup Score: 0NYU Langone Health Ranks No. 1 in New York & No. 3 in the Nation - 1 year(s) ago
NYU Langone Health is the No. 1 hospital in New York and No. 3 in the country, and also the No. 1 hospital for neurology and neurosurgery. Learn more.
Source: NYU Langone NewsCategories: Cardiologists, Latest HeadlinesTweet
-
Mashup Score: 0Inverse association between apolipoprotein C-II and cardiovascular mortality: role of lipoprotein lipase activity modulation - 2 year(s) ago
AbstractAims. Apolipoprotein C-II (ApoC-II) is thought to activate lipoprotein lipase (LPL) and is therefore a possible target for treating hypertriglyceridemia
Source: OUP AcademicCategories: Cardiologists, Latest HeadlinesTweet-
Inverse association between apolipoprotein C-II and cardiovascular mortality: role of lipoprotein lipase activity modulation and accompanying editorial via https://t.co/UXBwSWQeGT https://t.co/D9iGZnZcey https://t.co/kVyhmWPXRD
-
-
Mashup Score: 4
It is unclear to what extent genetic testing improves the ability to diagnose familial hypercholesterolaemia (FH). We investigated the percentage with FH among individuals referred to Danish lipid clinics, and evaluated the impact of genetic testing for a diagnosis of FH.
Source: AtherosclerosisCategories: Cardiologists, Latest HeadlinesTweet-
Genetic testing increased the diagnoses of FH from 22% to 37% in patients referred to lipid clinics with hypercholesterolemia suspected of FH in Danish national study #KnowFH . Via @ATHjournal @fhpatienteurope @foundationofnla @TheFHFoundation https://t.co/uilqS3UfFO https://t.co/tdj8CqvXfP
-
-
Mashup Score: 1LDL cholesterol targets rarely achieved in familial hypercholesterolemia patients: A sex and gender-specific analysis - 2 year(s) ago
Despite lipid lowering therapy (LLT), reaching LDL-C targets in patients with familial hypercholesterolemia (FH) remains challenging. Our aim was to determine attainment of LDL-C target levels and reasons for not reaching these in female and male FH patients.
Source: AtherosclerosisCategories: Cardiologists, Latest HeadlinesTweet-
LDL-C targets rarely achieved in FH patients: A sex & gender-specific analysis Women w. higher pretreatment LDL & ⬇️ High intensity Statin use @ATHjournal #KnowFH #TreatFH @fhpatienteurope @TheFHFoundation @foundationofnla @nationallipid @NYUCVDPrevent https://t.co/Q88QuIj1mv https://t.co/yWTLVIuLkF
-
-
Mashup Score: 1The Lipid Panel | National Lipid Association Online - 2 year(s) ago
National Lipid Association
Source: www.lipid.orgCategories: Cardiologists, Latest HeadlinesTweet-
Another great installment of #TheLipidPanel @nationallipid https://t.co/GRSQxdOTRG Low ⬇️LDL-C & Risk for Hemorrhagic🩸 Stroke 🧠Tuesday April 8 at 8PM ET https://t.co/gbCi3GbuY5 https://t.co/6dM0PoilUk
-
-
Mashup Score: 0Source: link.springer.comCategories: Cardiologists, Latest HeadlinesTweet
-
Structure-based mechanism and inhibition of cholesteryl ester transfer protein from Current Atherosclerosis Reports https://t.co/hj5fGcYuJA https://t.co/2Ah3KTPyzY
-
-
Mashup Score: 0
TUESDAY, April 11, 2023 (American Heart Association News) — People who strongly adhere to a set of cardiovascular health metrics may live close to a decade longer than those who don’t, new research suggests.The study, published Monday in Circulation, found people with higher scores for cardiovascul…
Source: Consumer Health News | HealthDayCategories: Cardiologists, Latest HeadlinesTweet-
https://t.co/GRnAVhVBJ3
-
-
Mashup Score: 0Statins Cut Heart Risks for Folks Living With HIV - 2 year(s) ago
THURSDAY, April 13, 2023 (HealthDay News) — As people with HIV live longer they’re at risk of premature heart disease. But a new study finds statin drugs can cut the risk of serious heart problems by more than one-third.The U.S. National Institutes of Health trial found the cholesterol-lowering dru…
Source: Consumer Health News | HealthDayCategories: Cardiologists, Latest HeadlinesTweet-
https://t.co/BIpTF7bmyP
-
-
Mashup Score: 0
1:00 PMWelcome and Introductory RemarksMelanie Brickman Borchard, PhD, MSc, The New York Academy of SciencesKevin J. Tracey, MD, The Feinstein Institutes for Medical ResearchJack and Robin Ross, The Feinstein Institutes for Medical Research Board of DirectorsSession I: 2023 Ross Prize in Molecular Medicine Presentation and LectureSession Chair: Betty Diamond, MD, The Feinstein Institutes for…
Source: events.nyas.orgCategories: Cardiologists, Latest HeadlinesTweet-
For all my #lipid colleagues @NYASciences is hosting 2023 #RossPrize Symposium - Genetic Basis of Lipid Metabolism Disorders 05/31/23 In-person & Virtual 1230-545 pm Keynote speakers Dr. Jonathan Cohen & Dr Helen Hobbs @SpringerNature @NorthwellHealth https://t.co/TsVpr5miTf https://t.co/SapAwg4Fhf
-
-
Mashup Score: 2FCS in Children: Webinar - Action FCS is the UK charity for people affected by Familial Chylomicronaemia Syndrome (FCS) - 2 year(s) ago
7pm-8pm BST Wednesday 26th April 2023 Join us to hear our four speakers to learn more about managing FCS in childhood.
Categories: Cardiologists, Latest HeadlinesTweet-
RT @ActionFCS: Join us for our webinar FCS in children. For more information https://t.co/Xq7t7KLXrY #FCS #raredisease @livingwithfcs @fhpa…
-
Proud To call this my home @nyulangone NYU Langone Health Ranks No. 1 in New York & No. 3 in the Nation https://t.co/74Gn9dQsfQ